Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Michael P. Everson"'
Publikováno v:
Annals of the New York Academy of Sciences. 966:327-342
The underlying etiology and pathogenesis of Gulf War veterans' illnesses continue to be under intense investigation. Reports have suggested the basis for these illnesses may be an altered immune system, but compelling evidence is lacking. We sought t
Publikováno v:
Annals of the New York Academy of Sciences. 876:413-418
The role of stress and immunological abnormalities, as well as the neuroendocrine regulation of these two variables, in illnesses in Gulf War veterans (GWVs) is unknown. Many GWV patients complain of skin and joint problems, that is, disorders that m
Autor:
David G. Lemak, Michael P. Everson, Kenneth W. Beagley, William J. Koopman, Jerry R. McGhee, Deborrah S. McDuffie
Publikováno v:
Journal of Leukocyte Biology. 59:494-498
The precise role of antigen-presenting cells (APC) in regulating the balance of T-helper type 1 (Th1) and T-helper type 2 (Th2) cytokine production is unclear. Dendritic cells (DC), the most potent APC for activation of naive T cells, were found to r
Autor:
John F. Neylan, Gabriel M. Danovitch, Robert W. Steiner, Michael P. Everson, Flavio Vincenti, Robert S. Gaston
Publikováno v:
Transplantation. 61:573-577
The use of OKT3 as an immunosuppressive agent is accompanied by increased cytokine production and constellation of side effects collectively termed cytokine release syndrome (CRS). Pentoxifylline (PTF) inhibits synthesis of some cytokines, and has be
Publikováno v:
American Journal of Therapeutics. 2:626-629
Dendritic cells (DC) from blood and other tissues are potent accessory cells for primary immune responses. Because prostaglandins from monocytes and macrophages can suppress DC and T-cell function, we sought to investigate the binding properties of m
Publikováno v:
International Journal of Immunopharmacology. 15:309-317
The capacity of retinoids to amplify the proliferative response of BALB/c lymphocytes to concanavalin A (Con A) 2 in the presence of exogenous interleukin-2 (IL-2) and the induction of IL-2 receptors (IL-2R) on L3T4 + and Lyt-2 + T-cells was evaluate
Autor:
CHARLES LINDAMOOD, FREDERICK O. COPE, DIRCK L. DILLEHAY, MICHAEL P. EVERSON, HERSCHELL D. GILES, EDDIE W. LAMON, DENNIS J. MCCARTHY, JAMES L. SARTIN, DONALD L. HILL
Publikováno v:
Toxicological Sciences. 14:15-29
Autor:
Donald L. Hill, Frederick O. Cope, Dennis J. McCarthy, James L. Sartin, Eddie W. Lamon, Michael P. Everson, Charles Lindamood, Dirck L. Dillehay, Herschell D. Giles
Publikováno v:
Fundamental and Applied Toxicology. 14:15-29
Studies were conducted to define primary pharmacological and toxicological properties of two arotinoids, SMR-2 and SMR-6, in male B6D2F1 mice. Mice were gavaged daily for up to 22 days with retinoids in corn oil (0.1, 0.2, or 0.4 mg/kg day SMR-2 or S
Autor:
Catherine D. Bacheller, Joseph Lentino, Marvin J. Bittner, Edward S. Wong, Richard J. Hamill, Lisa L. Dever, Manisha Thakore, Kenneth H. Wilson, Jack M. Bernstein, Luis Montalvo, Rebecca A. Horney, Annette L. Wiseman, Margaret A. K. Ryan, Kathy D. Boardman, James K. Schmitt, Christopher Nice, Victor Gordan, Dorothy Norwood, Cliff Robinson, Fredric Silverblatt, Pierre DeJace, David R. Wagner, Joel B. Baseman, Lisa Beck, Arnold B. Gorin, L. W. Preston Church, Bruce S. Ribner, Prabhakar Guduru, Christine Handanos, Lewis E. Kazis, Michael P. Everson, Larry I. Lutwick, Douglas S. Kernodle, Sam T. Donta, Suzanne E. Martin, Thomas Taylor, John R. Feussner, H. Ralph Schumacher, Warren D. Blackburn, Charles C. Engel, Aldona L. Baltch, Raymond P. Smith, Ronald Greenfield, Javier Figueroa, Brian Catto, Sheldon T. Brown, Joseph F. Collins, Robert Cooper
Publikováno v:
Annals of internal medicine. 141(2)
Background It has been hypothesized that certain Mycoplasma species may cause Gulf War veterans' illnesses (GWVIs), chronic diseases characterized by pain, fatigue, and cognitive symptoms, and that affected patients may benefit from doxycycline treat
Publikováno v:
Plastic and reconstructive surgery. 99(4)
Breast implants containing silicone have been used for approximately 30 years for breast augmentation or reconstruction. In general, the implants have been well tolerated and reports have indicated a high degree of patient satisfaction. Nonetheless,